Flare of Antiphospholipid Syndrome in the Course of COVID-19.
Identifieur interne : 001284 ( Main/Exploration ); précédent : 001283; suivant : 001285Flare of Antiphospholipid Syndrome in the Course of COVID-19.
Auteurs : Alexandre Thibault Jacques Maria [France] ; Isabelle Diaz-Cau [France] ; Jean-Marc Benejean [France] ; Anaïs Nutz [France] ; Aurélie Schiffmann [France] ; Christine Biron-Andreani [France] ; Philippe Guilpain [France]Source :
- TH open : companion journal to thrombosis and haemostasis [ 2512-9465 ] ; 2020.
Abstract
We report the case of a 48-year-old man followed since 2013 for primary antiphospholipid syndrome (APLS) revealed by venous thromboembolism in the presence of antiphospholipid antibodies (APL-Abs, anticardiolipin and anti-β-2-glycoprotein-1), who decompensated in the course of coronavirus disease (COVID-19). Despite efficient anticoagulation, he suffered bilateral adrenal glands hemorrhage and limb arterial ischemia. The tropism of severe acute respiratory syndrome coronavirus-2 for endothelium can lead to microangiopathy and increased risk for thrombosis. If APL-Abs positivity can be an epiphenomenon under inflammatory and prothrombotic conditions, COVID-19 was herein responsible for disseminated thrombosis and a threat of catastrophic APLS, despite efficient anticoagulation.
DOI: 10.1055/s-0040-1716735
PubMed: 32935073
PubMed Central: PMC7486139
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Flare of Antiphospholipid Syndrome in the Course of COVID-19.</title><author><name sortKey="Maria, Alexandre Thibault Jacques" sort="Maria, Alexandre Thibault Jacques" uniqKey="Maria A" first="Alexandre Thibault Jacques" last="Maria">Alexandre Thibault Jacques Maria</name><affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine-Multi-organ Diseases, Local Referral Center for Auto-immune Diseases, Montpellier School of Medicine, Saint-Eloi University Hospital, University of Montpellier, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Internal Medicine-Multi-organ Diseases, Local Referral Center for Auto-immune Diseases, Montpellier School of Medicine, Saint-Eloi University Hospital, University of Montpellier, Montpellier</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Montpellier</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>IRMB, Inserm U1183, CHU Montpellier (Saint-Eloi University Hospital), University of Montpellier, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>IRMB, Inserm U1183, CHU Montpellier (Saint-Eloi University Hospital), University of Montpellier, Montpellier</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Montpellier</settlement></placeName></affiliation></author><author><name sortKey="Diaz Cau, Isabelle" sort="Diaz Cau, Isabelle" uniqKey="Diaz Cau I" first="Isabelle" last="Diaz-Cau">Isabelle Diaz-Cau</name><affiliation wicri:level="3"><nlm:affiliation>Hemostasis Laboratory, Referral Center for Hemophilia, Montpellier University Hospital, Saint-Eloi University Hospital, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hemostasis Laboratory, Referral Center for Hemophilia, Montpellier University Hospital, Saint-Eloi University Hospital, Montpellier</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Montpellier</settlement></placeName></affiliation></author><author><name sortKey="Benejean, Jean Marc" sort="Benejean, Jean Marc" uniqKey="Benejean J" first="Jean-Marc" last="Benejean">Jean-Marc Benejean</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiology, Narbonne Hospital, Narbonne, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Radiology, Narbonne Hospital, Narbonne</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Narbonne</settlement></placeName></affiliation></author><author><name sortKey="Nutz, Anais" sort="Nutz, Anais" uniqKey="Nutz A" first="Anaïs" last="Nutz">Anaïs Nutz</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medicine and Endocrinology, Narbonne Hospital, Narbonne, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Medicine and Endocrinology, Narbonne Hospital, Narbonne</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Narbonne</settlement></placeName></affiliation></author><author><name sortKey="Schiffmann, Aurelie" sort="Schiffmann, Aurelie" uniqKey="Schiffmann A" first="Aurélie" last="Schiffmann">Aurélie Schiffmann</name><affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine-Multi-organ Diseases, Local Referral Center for Auto-immune Diseases, Montpellier School of Medicine, Saint-Eloi University Hospital, University of Montpellier, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Internal Medicine-Multi-organ Diseases, Local Referral Center for Auto-immune Diseases, Montpellier School of Medicine, Saint-Eloi University Hospital, University of Montpellier, Montpellier</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Montpellier</settlement></placeName></affiliation></author><author><name sortKey="Biron Andreani, Christine" sort="Biron Andreani, Christine" uniqKey="Biron Andreani C" first="Christine" last="Biron-Andreani">Christine Biron-Andreani</name><affiliation wicri:level="3"><nlm:affiliation>Hemostasis Laboratory, Referral Center for Hemophilia, Montpellier University Hospital, Saint-Eloi University Hospital, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hemostasis Laboratory, Referral Center for Hemophilia, Montpellier University Hospital, Saint-Eloi University Hospital, Montpellier</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Montpellier</settlement></placeName></affiliation></author><author><name sortKey="Guilpain, Philippe" sort="Guilpain, Philippe" uniqKey="Guilpain P" first="Philippe" last="Guilpain">Philippe Guilpain</name><affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine-Multi-organ Diseases, Local Referral Center for Auto-immune Diseases, Montpellier School of Medicine, Saint-Eloi University Hospital, University of Montpellier, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Internal Medicine-Multi-organ Diseases, Local Referral Center for Auto-immune Diseases, Montpellier School of Medicine, Saint-Eloi University Hospital, University of Montpellier, Montpellier</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Montpellier</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>IRMB, Inserm U1183, CHU Montpellier (Saint-Eloi University Hospital), University of Montpellier, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>IRMB, Inserm U1183, CHU Montpellier (Saint-Eloi University Hospital), University of Montpellier, Montpellier</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Montpellier</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32935073</idno><idno type="pmid">32935073</idno><idno type="doi">10.1055/s-0040-1716735</idno><idno type="pmc">PMC7486139</idno><idno type="wicri:Area/Main/Corpus">000C11</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000C11</idno><idno type="wicri:Area/Main/Curation">000C11</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000C11</idno><idno type="wicri:Area/Main/Exploration">000C11</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Flare of Antiphospholipid Syndrome in the Course of COVID-19.</title><author><name sortKey="Maria, Alexandre Thibault Jacques" sort="Maria, Alexandre Thibault Jacques" uniqKey="Maria A" first="Alexandre Thibault Jacques" last="Maria">Alexandre Thibault Jacques Maria</name><affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine-Multi-organ Diseases, Local Referral Center for Auto-immune Diseases, Montpellier School of Medicine, Saint-Eloi University Hospital, University of Montpellier, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Internal Medicine-Multi-organ Diseases, Local Referral Center for Auto-immune Diseases, Montpellier School of Medicine, Saint-Eloi University Hospital, University of Montpellier, Montpellier</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Montpellier</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>IRMB, Inserm U1183, CHU Montpellier (Saint-Eloi University Hospital), University of Montpellier, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>IRMB, Inserm U1183, CHU Montpellier (Saint-Eloi University Hospital), University of Montpellier, Montpellier</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Montpellier</settlement></placeName></affiliation></author><author><name sortKey="Diaz Cau, Isabelle" sort="Diaz Cau, Isabelle" uniqKey="Diaz Cau I" first="Isabelle" last="Diaz-Cau">Isabelle Diaz-Cau</name><affiliation wicri:level="3"><nlm:affiliation>Hemostasis Laboratory, Referral Center for Hemophilia, Montpellier University Hospital, Saint-Eloi University Hospital, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hemostasis Laboratory, Referral Center for Hemophilia, Montpellier University Hospital, Saint-Eloi University Hospital, Montpellier</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Montpellier</settlement></placeName></affiliation></author><author><name sortKey="Benejean, Jean Marc" sort="Benejean, Jean Marc" uniqKey="Benejean J" first="Jean-Marc" last="Benejean">Jean-Marc Benejean</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiology, Narbonne Hospital, Narbonne, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Radiology, Narbonne Hospital, Narbonne</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Narbonne</settlement></placeName></affiliation></author><author><name sortKey="Nutz, Anais" sort="Nutz, Anais" uniqKey="Nutz A" first="Anaïs" last="Nutz">Anaïs Nutz</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medicine and Endocrinology, Narbonne Hospital, Narbonne, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Medicine and Endocrinology, Narbonne Hospital, Narbonne</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Narbonne</settlement></placeName></affiliation></author><author><name sortKey="Schiffmann, Aurelie" sort="Schiffmann, Aurelie" uniqKey="Schiffmann A" first="Aurélie" last="Schiffmann">Aurélie Schiffmann</name><affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine-Multi-organ Diseases, Local Referral Center for Auto-immune Diseases, Montpellier School of Medicine, Saint-Eloi University Hospital, University of Montpellier, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Internal Medicine-Multi-organ Diseases, Local Referral Center for Auto-immune Diseases, Montpellier School of Medicine, Saint-Eloi University Hospital, University of Montpellier, Montpellier</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Montpellier</settlement></placeName></affiliation></author><author><name sortKey="Biron Andreani, Christine" sort="Biron Andreani, Christine" uniqKey="Biron Andreani C" first="Christine" last="Biron-Andreani">Christine Biron-Andreani</name><affiliation wicri:level="3"><nlm:affiliation>Hemostasis Laboratory, Referral Center for Hemophilia, Montpellier University Hospital, Saint-Eloi University Hospital, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hemostasis Laboratory, Referral Center for Hemophilia, Montpellier University Hospital, Saint-Eloi University Hospital, Montpellier</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Montpellier</settlement></placeName></affiliation></author><author><name sortKey="Guilpain, Philippe" sort="Guilpain, Philippe" uniqKey="Guilpain P" first="Philippe" last="Guilpain">Philippe Guilpain</name><affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine-Multi-organ Diseases, Local Referral Center for Auto-immune Diseases, Montpellier School of Medicine, Saint-Eloi University Hospital, University of Montpellier, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Internal Medicine-Multi-organ Diseases, Local Referral Center for Auto-immune Diseases, Montpellier School of Medicine, Saint-Eloi University Hospital, University of Montpellier, Montpellier</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Montpellier</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>IRMB, Inserm U1183, CHU Montpellier (Saint-Eloi University Hospital), University of Montpellier, Montpellier, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>IRMB, Inserm U1183, CHU Montpellier (Saint-Eloi University Hospital), University of Montpellier, Montpellier</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Montpellier</settlement></placeName></affiliation></author></analytic><series><title level="j">TH open : companion journal to thrombosis and haemostasis</title><idno type="eISSN">2512-9465</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We report the case of a 48-year-old man followed since 2013 for primary antiphospholipid syndrome (APLS) revealed by venous thromboembolism in the presence of antiphospholipid antibodies (APL-Abs, anticardiolipin and anti-β-2-glycoprotein-1), who decompensated in the course of coronavirus disease (COVID-19). Despite efficient anticoagulation, he suffered bilateral adrenal glands hemorrhage and limb arterial ischemia. The tropism of severe acute respiratory syndrome coronavirus-2 for endothelium can lead to microangiopathy and increased risk for thrombosis. If APL-Abs positivity can be an epiphenomenon under inflammatory and prothrombotic conditions, COVID-19 was herein responsible for disseminated thrombosis and a threat of catastrophic APLS, despite efficient anticoagulation.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32935073</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2512-9465</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>TH open : companion journal to thrombosis and haemostasis</Title><ISOAbbreviation>TH Open</ISOAbbreviation></Journal><ArticleTitle>Flare of Antiphospholipid Syndrome in the Course of COVID-19.</ArticleTitle><Pagination><MedlinePgn>e207-e210</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0040-1716735</ELocationID><Abstract><AbstractText>We report the case of a 48-year-old man followed since 2013 for primary antiphospholipid syndrome (APLS) revealed by venous thromboembolism in the presence of antiphospholipid antibodies (APL-Abs, anticardiolipin and anti-β-2-glycoprotein-1), who decompensated in the course of coronavirus disease (COVID-19). Despite efficient anticoagulation, he suffered bilateral adrenal glands hemorrhage and limb arterial ischemia. The tropism of severe acute respiratory syndrome coronavirus-2 for endothelium can lead to microangiopathy and increased risk for thrombosis. If APL-Abs positivity can be an epiphenomenon under inflammatory and prothrombotic conditions, COVID-19 was herein responsible for disseminated thrombosis and a threat of catastrophic APLS, despite efficient anticoagulation.</AbstractText><CopyrightInformation>The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maria</LastName><ForeName>Alexandre Thibault Jacques</ForeName><Initials>ATJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine-Multi-organ Diseases, Local Referral Center for Auto-immune Diseases, Montpellier School of Medicine, Saint-Eloi University Hospital, University of Montpellier, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRMB, Inserm U1183, CHU Montpellier (Saint-Eloi University Hospital), University of Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz-Cau</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Hemostasis Laboratory, Referral Center for Hemophilia, Montpellier University Hospital, Saint-Eloi University Hospital, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benejean</LastName><ForeName>Jean-Marc</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Radiology, Narbonne Hospital, Narbonne, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nutz</LastName><ForeName>Anaïs</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine and Endocrinology, Narbonne Hospital, Narbonne, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schiffmann</LastName><ForeName>Aurélie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine-Multi-organ Diseases, Local Referral Center for Auto-immune Diseases, Montpellier School of Medicine, Saint-Eloi University Hospital, University of Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biron-Andreani</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hemostasis Laboratory, Referral Center for Hemophilia, Montpellier University Hospital, Saint-Eloi University Hospital, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guilpain</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine-Multi-organ Diseases, Local Referral Center for Auto-immune Diseases, Montpellier School of Medicine, Saint-Eloi University Hospital, University of Montpellier, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRMB, Inserm U1183, CHU Montpellier (Saint-Eloi University Hospital), University of Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>TH Open</MedlineTA><NlmUniqueID>101715740</NlmUniqueID><ISSNLinking>2512-9465</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">antiphospholipid syndrome</Keyword><Keyword MajorTopicYN="N">hydroxychloroquine</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">thrombosis</Keyword></KeywordList><CoiStatement>Conflict of Interest A.T.J.M. declares speaking fees from Sanofi, AstraZeneca, and Bristol Myers Squibb in the last 36 months. P.G. has been a medical expert for LFB (Laboratoire Français du Biofractionnement) and has received fees from Actelion, Novartis, and Pfizer in the last 36 months. The other authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>05</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>08</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>16</Day><Hour>5</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32935073</ArticleId><ArticleId IdType="doi">10.1055/s-0040-1716735</ArticleId><ArticleId IdType="pii">200028</ArticleId><ArticleId IdType="pmc">PMC7486139</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am J Clin Pathol. 2020 May 5;153(6):725-733</Citation><ArticleIdList><ArticleId IdType="pubmed">32275742</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 2020 Jul;146(1):215-217</Citation><ArticleIdList><ArticleId IdType="pubmed">32417135</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2020 Jun 30;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32608159</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):4040-4047</Citation><ArticleIdList><ArticleId IdType="pubmed">32329881</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2006 Feb;4(2):295-306</Citation><ArticleIdList><ArticleId IdType="pubmed">16420554</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 May 2;395(10234):1417-1418</Citation><ArticleIdList><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2020 Jun;18(6):1421-1424</Citation><ArticleIdList><ArticleId IdType="pubmed">32271988</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2020 May;18(5):1023-1026</Citation><ArticleIdList><ArticleId IdType="pubmed">32338827</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Derm Venereol. 2020 Apr 23;100(8):adv00124</Citation><ArticleIdList><ArticleId IdType="pubmed">32315073</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2020 Apr;18(4):786-787</Citation><ArticleIdList><ArticleId IdType="pubmed">32212240</ArticleId></ArticleIdList></Reference><Reference><Citation>Trials. 2020 Jul 13;21(1):639</Citation><ArticleIdList><ArticleId IdType="pubmed">32660611</ArticleId></ArticleIdList></Reference><Reference><Citation>Transl Res. 2020 Jun;220:1-13</Citation><ArticleIdList><ArticleId IdType="pubmed">32299776</ArticleId></ArticleIdList></Reference><Reference><Citation>J Intern Med. 2020 Jun 12;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32529774</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Apr 23;382(17):e38</Citation><ArticleIdList><ArticleId IdType="pubmed">32268022</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmun Rev. 2008 Feb;7(4):272-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18295729</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2020 May 14;181(4):905-913.e7</Citation><ArticleIdList><ArticleId IdType="pubmed">32333836</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2020 Aug;18(8):2064-2065</Citation><ArticleIdList><ArticleId IdType="pubmed">32324958</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Jun 18;382(25):2478-2480</Citation><ArticleIdList><ArticleId IdType="pubmed">32302081</ArticleId></ArticleIdList></Reference><Reference><Citation>Thromb Res. 2020 Jul 8;195:74-76</Citation><ArticleIdList><ArticleId IdType="pubmed">32663703</ArticleId></ArticleIdList></Reference><Reference><Citation>Auto Immun Highlights. 2011 Mar 24;2(2):35-52</Citation><ArticleIdList><ArticleId IdType="pubmed">26000118</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2020 Apr;18(4):844-847</Citation><ArticleIdList><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2020 Jun;20(6):343-344</Citation><ArticleIdList><ArticleId IdType="pubmed">32327719</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2020 Jul 3;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32619328</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2020 Jun 30;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32602200</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2020 Jul;18(7):1559-1561</Citation><ArticleIdList><ArticleId IdType="pubmed">32302453</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Languedoc-Roussillon</li><li>Occitanie (région administrative)</li></region><settlement><li>Montpellier</li><li>Narbonne</li></settlement></list><tree><country name="France"><region name="Occitanie (région administrative)"><name sortKey="Maria, Alexandre Thibault Jacques" sort="Maria, Alexandre Thibault Jacques" uniqKey="Maria A" first="Alexandre Thibault Jacques" last="Maria">Alexandre Thibault Jacques Maria</name></region><name sortKey="Benejean, Jean Marc" sort="Benejean, Jean Marc" uniqKey="Benejean J" first="Jean-Marc" last="Benejean">Jean-Marc Benejean</name><name sortKey="Biron Andreani, Christine" sort="Biron Andreani, Christine" uniqKey="Biron Andreani C" first="Christine" last="Biron-Andreani">Christine Biron-Andreani</name><name sortKey="Diaz Cau, Isabelle" sort="Diaz Cau, Isabelle" uniqKey="Diaz Cau I" first="Isabelle" last="Diaz-Cau">Isabelle Diaz-Cau</name><name sortKey="Guilpain, Philippe" sort="Guilpain, Philippe" uniqKey="Guilpain P" first="Philippe" last="Guilpain">Philippe Guilpain</name><name sortKey="Guilpain, Philippe" sort="Guilpain, Philippe" uniqKey="Guilpain P" first="Philippe" last="Guilpain">Philippe Guilpain</name><name sortKey="Maria, Alexandre Thibault Jacques" sort="Maria, Alexandre Thibault Jacques" uniqKey="Maria A" first="Alexandre Thibault Jacques" last="Maria">Alexandre Thibault Jacques Maria</name><name sortKey="Nutz, Anais" sort="Nutz, Anais" uniqKey="Nutz A" first="Anaïs" last="Nutz">Anaïs Nutz</name><name sortKey="Schiffmann, Aurelie" sort="Schiffmann, Aurelie" uniqKey="Schiffmann A" first="Aurélie" last="Schiffmann">Aurélie Schiffmann</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001284 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001284 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32935073
|texte= Flare of Antiphospholipid Syndrome in the Course of COVID-19.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32935073" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |